ReP USP - Resultado da busca

Artigo de periodico
Identification of pan-flavivirus compounds from drug repurposing (2025)
Eddine, Fatima Zahra Lissane; Mathez, Gregory ; Carlen, Vincent; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Laleu, Benoît; Cagno, Valeria
Fonte: Antiviral Research. Unidade: IFSC
Assuntos: ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EDDINE, Fatima Zahra Lissane et al. Identification of pan-flavivirus compounds from drug repurposing. Antiviral Research, v. 240, p. 106205-1-106205-9 + supplementary data, 2025Tradução . . Disponível em: https://doi.org/10.1016/j.antiviral.2025.106205. Acesso em: 08 out. 2025.
APA
Eddine, F. Z. L., Mathez, G., Carlen, V., Dolci, I., Fernandes, R. S., Godoy, A. S. de, et al. (2025). Identification of pan-flavivirus compounds from drug repurposing. Antiviral Research, 240, 106205-1-106205-9 + supplementary data. doi:10.1016/j.antiviral.2025.106205
NLM
Eddine FZL, Mathez G, Carlen V, Dolci I, Fernandes RS, Godoy AS de, Laleu B, Cagno V. Identification of pan-flavivirus compounds from drug repurposing [Internet]. Antiviral Research. 2025 ; 240 106205-1-106205-9 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.antiviral.2025.106205
Vancouver
Eddine FZL, Mathez G, Carlen V, Dolci I, Fernandes RS, Godoy AS de, Laleu B, Cagno V. Identification of pan-flavivirus compounds from drug repurposing [Internet]. Antiviral Research. 2025 ; 240 106205-1-106205-9 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.antiviral.2025.106205
Artigo de periodico
Compounds isolated from Paepalanthus spp. (Eriocaulaceae) and their evaluation in antimicrobial, cytotoxic, and antiviral assays (2025)
Moreira, Laysa Lanes Pereira Ferreira ; Oliveira, Lucas Almeida; Conti, Raphael; Almeida, Larissa Costa de ; Costa-Lotufo, Letícia Veras ; Micheletti, Ana Camila ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho ; Lacerda Júnior, Valdemar ; Borges, Keyller Bastos ; Borges, Warley de Souza
Fonte: ACS Omega. Unidades: ICB, IFSC
Assuntos: FLAVONOIDES, NEOPLASIAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, PLANTAS HERBÁCEAS, EXTRATOS (FORMAS FARMACÊUTICAS), ATIVAÇÃO ENZIMÁTICA, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Laysa Lanes Pereira Ferreira et al. Compounds isolated from Paepalanthus spp. (Eriocaulaceae) and their evaluation in antimicrobial, cytotoxic, and antiviral assays. ACS Omega, v. 10, n. 25, p. 26403-26414 + supporting information, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsomega.4c11026. Acesso em: 08 out. 2025.
APA
Moreira, L. L. P. F., Oliveira, L. A., Conti, R., Almeida, L. C. de, Costa-Lotufo, L. V., Micheletti, A. C., et al. (2025). Compounds isolated from Paepalanthus spp. (Eriocaulaceae) and their evaluation in antimicrobial, cytotoxic, and antiviral assays. ACS Omega, 10( 25), 26403-26414 + supporting information. doi:10.1021/acsomega.4c11026
NLM
Moreira LLPF, Oliveira LA, Conti R, Almeida LC de, Costa-Lotufo LV, Micheletti AC, Dolci I, Fernandes RS, Oliva G, Guido RVC, Lacerda Júnior V, Borges KB, Borges W de S. Compounds isolated from Paepalanthus spp. (Eriocaulaceae) and their evaluation in antimicrobial, cytotoxic, and antiviral assays [Internet]. ACS Omega. 2025 ; 10( 25): 26403-26414 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.4c11026
Vancouver
Moreira LLPF, Oliveira LA, Conti R, Almeida LC de, Costa-Lotufo LV, Micheletti AC, Dolci I, Fernandes RS, Oliva G, Guido RVC, Lacerda Júnior V, Borges KB, Borges W de S. Compounds isolated from Paepalanthus spp. (Eriocaulaceae) and their evaluation in antimicrobial, cytotoxic, and antiviral assays [Internet]. ACS Omega. 2025 ; 10( 25): 26403-26414 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.4c11026
Artigo de periodico
Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors (2025)
Oliveira, Victor Gawriljuk Ferraro; Noske, Gabriela Dias ; Fernandes, Rafaela Sachetto ; Nakamura, Aline Minali ; Freire, Marjorie Caroline Liberato Cavalcanti ; Godoy, Mariana Ortiz de ; Bonatto, Vinícius ; Chelucci, Rafael Consolin ; Andricopulo, Adriano Defini ; Martins Júnior, Ronaldo Bragança ; Souza, Juliano de Paula ; Arruda, Eurico ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Fonte: ACS Omega. Unidades: IFSC, FCFRP, FMRP
Assuntos: PROTEÍNAS, MALÁRIA, PLANEJAMENTO DE FÁRMACOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Victor Gawriljuk Ferraro et al. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, v. 10, n. 37, p. 42711-42724 + supporting information, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsomega.5c04858. Acesso em: 08 out. 2025.
APA
Oliveira, V. G. F., Noske, G. D., Fernandes, R. S., Nakamura, A. M., Freire, M. C. L. C., Godoy, M. O. de, et al. (2025). Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, 10( 37), 42711-42724 + supporting information. doi:10.1021/acsomega.5c04858
NLM
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Vancouver
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Trabalho de evento-resumo
Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries (2025)
Dolci, Isabela ; Cipriano, Lavinia; Noske, Gabriela Dias ; Godoy, Andre Schutzer de ; Fairhead, Michael; Fernandes, Rafaela Sachetto ; Oliva, Glaucius
Fonte: Abstracts. Nome do evento: FEBS Congress. Unidade: IFSC
Assuntos: ZIKA VÍRUS, DENGUE, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOLCI, Isabela et al. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries. 2025, Anais.. Cambridge: Federation of European Biochemical Societies - FEBS, 2025. Disponível em: https://2025.febscongress.org/abstract_preview.aspx?idAbstractEnc=4424170096100099100096424170. Acesso em: 08 out. 2025.
APA
Dolci, I., Cipriano, L., Noske, G. D., Godoy, A. S. de, Fairhead, M., Fernandes, R. S., & Oliva, G. (2025). Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries. In Abstracts. Cambridge: Federation of European Biochemical Societies - FEBS. Recuperado de https://2025.febscongress.org/abstract_preview.aspx?idAbstractEnc=4424170096100099100096424170
NLM
Dolci I, Cipriano L, Noske GD, Godoy AS de, Fairhead M, Fernandes RS, Oliva G. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries [Internet]. Abstracts. 2025 ;[citado 2025 out. 08 ] Available from: https://2025.febscongress.org/abstract_preview.aspx?idAbstractEnc=4424170096100099100096424170
Vancouver
Dolci I, Cipriano L, Noske GD, Godoy AS de, Fairhead M, Fernandes RS, Oliva G. Identification of potent inhibitors of Zika and Dengue viruses proteases from smallmolecule compound libraries [Internet]. Abstracts. 2025 ;[citado 2025 out. 08 ] Available from: https://2025.febscongress.org/abstract_preview.aspx?idAbstractEnc=4424170096100099100096424170
Artigo de periodico
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors (2025)
Ni, Xiaomin ; Godoy, Andre Schutzer de ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Oliva, Glaucius
Fonte: Nature Communications. Unidade: IFSC
Assuntos: ZIKA VÍRUS, VÍRUS, DENGUE, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NI, Xiaomin et al. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, v. 16, p. 8930-1-8930-13 + supplementary information, 2025Tradução . . Disponível em: https://doi.org/10.1038/s41467-025-63602-z. Acesso em: 08 out. 2025.
APA
Ni, X., Godoy, A. S. de, Dolci, I., Fernandes, R. S., & Oliva, G. (2025). Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors. Nature Communications, 16, 8930-1-8930-13 + supplementary information. doi:10.1038/s41467-025-63602-z
NLM
Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
Vancouver
Ni X, Godoy AS de, Dolci I, Fernandes RS, Oliva G. Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors [Internet]. Nature Communications. 2025 ; 16 8930-1-8930-13 + supplementary information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41467-025-63602-z
Trabalho de evento-resumo
Structural and biochemical characterization of SARS-CoV-2 Main Protease maturation process (2024)
Noske, Gabriela Dias ; Godoy, Andre Schutzer de ; Fernandes, Rafaela Sachetto ; Oliva, Glaucius
Fonte: Livro de Resumos. Nome do evento: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology - SBBq. Unidade: IFSC
Assuntos: COVID-19, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural and biochemical characterization of SARS-CoV-2 Main Protease maturation process. 2024, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq, 2024. Disponível em: https://repositorio.usp.br/directbitstream/234be8d2-70b3-4b21-8c94-f3296b19ddf4/3230429.pdf. Acesso em: 08 out. 2025.
APA
Noske, G. D., Godoy, A. S. de, Fernandes, R. S., & Oliva, G. (2024). Structural and biochemical characterization of SARS-CoV-2 Main Protease maturation process. In Livro de Resumos. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular - SBBq. Recuperado de https://repositorio.usp.br/directbitstream/234be8d2-70b3-4b21-8c94-f3296b19ddf4/3230429.pdf
NLM
Noske GD, Godoy AS de, Fernandes RS, Oliva G. Structural and biochemical characterization of SARS-CoV-2 Main Protease maturation process [Internet]. Livro de Resumos. 2024 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/234be8d2-70b3-4b21-8c94-f3296b19ddf4/3230429.pdf
Vancouver
Noske GD, Godoy AS de, Fernandes RS, Oliva G. Structural and biochemical characterization of SARS-CoV-2 Main Protease maturation process [Internet]. Livro de Resumos. 2024 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/234be8d2-70b3-4b21-8c94-f3296b19ddf4/3230429.pdf
Artigo de periodico
An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition (2023)
Noske, Gabriela Dias; Song, Yun; Fernandes, Rafaela Sachetto ; Chalk, Rod; Elmassoudi, Haitem; Koekemoer, Lizbé; Owen, Christopher David ; El-Baba, Tarick John; Robinson, Dame Carol ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Fonte: Nature Communications. Unidade: IFSC
Assuntos: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, v. 14, p. 1545-1-1545-13 + supplementary information, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41467-023-37035-5. Acesso em: 08 out. 2025.
APA
Noske, G. D., Song, Y., Fernandes, R. S., Chalk, R., Elmassoudi, H., Koekemoer, L., et al. (2023). An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, 14, 1545-1-1545-13 + supplementary information. doi:10.1038/s41467-023-37035-5
NLM
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Vancouver
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Artigo de periodico
Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 (2023)
Puhl, Ana Cristina ; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto ; Oliva, Glaucius ; Ekins, Sean
Fonte: ACS Omega. Unidade: IFSC
Assuntos: COVID-19, PEPTÍDEOS, AGENTES ANTIMICROBIANOS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana Cristina et al. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, v. 8, n. 25, p. 22603-22612, 2023Tradução . . Disponível em: https://doi.org/10.1021/acsomega.3c01110. Acesso em: 08 out. 2025.
APA
Puhl, A. C., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., et al. (2023). Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, 8( 25), 22603-22612. doi:10.1021/acsomega.3c01110
NLM
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Vancouver
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Artigo de periodico
Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways (2023)
Ruiz, Uriel Enrique Aquino; Santos, Igor de Andrade; Grosche, Victória Riquena; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Torres, Jhoan David Aguillón; Freire, Marjorie Caroline Liberato Cavalcanti ; Mesquita, Nathalya Cristina de Moraes Roso; Vega, Marco Fidel Guevara; Nicolau Junior, Nilson; Silva, Robinson Sabino da ; Mineo, Tiago Wilson Patriarca; Oliva, Glaucius ; Jardim, Ana Carolina Gomes
Fonte: Virus Research. Unidade: IFSC
Assuntos: VÍRUS CHIKUNGUNYA, ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Uriel Enrique Aquino et al. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, v. 324, n. Ja 2023, p. 199029-1-199029-14 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2022.199029. Acesso em: 08 out. 2025.
APA
Ruiz, U. E. A., Santos, I. de A., Grosche, V. R., Fernandes, R. S., Godoy, A. S. de, Torres, J. D. A., et al. (2023). Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, 324( Ja 2023), 199029-1-199029-14 + supplementary materials. doi:10.1016/j.virusres.2022.199029
NLM
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Vancouver
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Artigo de periodico
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease (2023)
Noske, Gabriela Dias; Silva, Ellen de Souza; Godoy, Mariana Ortiz de ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Guido, Rafael Victorio Carvalho ; Sjo, Peter ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Fonte: Journal of Biological Chemistry. Unidade: IFSC
Assuntos: COVID-19, CORONAVIRUS, RESISTÊNCIA MICROBIANA ÀS DROGAS, MUTAÇÃO GENÉTICA, RAIOS X, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, v. 299, n. 3, p. 103004-1-103004-10 + supporting information: 1-3, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jbc.2023.103004. Acesso em: 08 out. 2025.
APA
Noske, G. D., Silva, E. de S., Godoy, M. O. de, Dolci, I., Fernandes, R. S., Guido, R. V. C., et al. (2023). Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, 299( 3), 103004-1-103004-10 + supporting information: 1-3. doi:10.1016/j.jbc.2023.103004
NLM
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Vancouver
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Artigo de periodico
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023)
Boby, Melissa L.; Fernandes, Rafaela Sachetto ; Gawriljuk, Victor Oliveira; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius ; Rangel, Victor Lopes
Fonte: Science. Unidades: IFSC, FCFRP
Assuntos: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 08 out. 2025.
APA
Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201
NLM
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.1126/science.abo7201
Vancouver
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.1126/science.abo7201
Artigo de periodico
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease (2023)
Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Douangamath, Alice; Song, Yun; Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto ; Pereira, Humberto d'Muniz ; Oliveira, Ketllyn Irene Zagato de; Fearon, Daren; Dias, Alexandre; Krojer, Tobias; Fairhead, Michael; Powell, Ailsa; Dunnet, Louise; Brandão Neto, José; Skyner, Rachael; Chalk, Rod; Bajusz, Dávid ; Bege, Miklós; Borbás, Anikó; Keseru, Gyorgy Miklós; von Delft, Frank ; Oliva, Glaucius
Fonte: Nucleic Acids Research. Unidade: IFSC
Assuntos: CRISTALOGRAFIA DE RAIOS X, COVID-19, AGENTES ANTIMICROBIANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Andre Schutzer de et al. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease. Nucleic Acids Research, v. 51, n. 10, p. 5255-5270 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1093/nar/gkad314. Acesso em: 08 out. 2025.
APA
Godoy, A. S. de, Nakamura, A. M., Douangamath, A., Song, Y., Noske, G. D., Gawriljuk, V. O., et al. (2023). Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease. Nucleic Acids Research, 51( 10), 5255-5270 + supplementary data. doi:10.1093/nar/gkad314
NLM
Godoy AS de, Nakamura AM, Douangamath A, Song Y, Noske GD, Gawriljuk VO, Fernandes RS, Pereira H d'M, Oliveira KIZ de, Fearon D, Dias A, Krojer T, Fairhead M, Powell A, Dunnet L, Brandão Neto J, Skyner R, Chalk R, Bajusz D, Bege M, Borbás A, Keseru GM, von Delft F, Oliva G. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease [Internet]. Nucleic Acids Research. 2023 ; 51( 10): 5255-5270 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/nar/gkad314
Vancouver
Godoy AS de, Nakamura AM, Douangamath A, Song Y, Noske GD, Gawriljuk VO, Fernandes RS, Pereira H d'M, Oliveira KIZ de, Fearon D, Dias A, Krojer T, Fairhead M, Powell A, Dunnet L, Brandão Neto J, Skyner R, Chalk R, Bajusz D, Bege M, Borbás A, Keseru GM, von Delft F, Oliva G. Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease [Internet]. Nucleic Acids Research. 2023 ; 51( 10): 5255-5270 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/nar/gkad314
Artigo de periodico
The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus (2023)
Puhl, Ana Cristina ; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Gil, Laura Helena Vega Gonzales; Oliva, Glaucius ; Ekins, Sean
Fonte: Bioorganic and Medicinal Chemistry. Unidade: IFSC
Assuntos: VÍRUS CHIKUNGUNYA, PROTEÍNAS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana Cristina et al. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Bioorganic and Medicinal Chemistry, v. 83, p. 117239-1-117239-8 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2023.117239. Acesso em: 08 out. 2025.
APA
Puhl, A. C., Fernandes, R. S., Godoy, A. S. de, Gil, L. H. V. G., Oliva, G., & Ekins, S. (2023). The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Bioorganic and Medicinal Chemistry, 83, 117239-1-117239-8 + supplementary data. doi:10.1016/j.bmc.2023.117239
NLM
Puhl AC, Fernandes RS, Godoy AS de, Gil LHVG, Oliva G, Ekins S. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus [Internet]. Bioorganic and Medicinal Chemistry. 2023 ; 83 117239-1-117239-8 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.bmc.2023.117239
Vancouver
Puhl AC, Fernandes RS, Godoy AS de, Gil LHVG, Oliva G, Ekins S. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus [Internet]. Bioorganic and Medicinal Chemistry. 2023 ; 83 117239-1-117239-8 + supplementary data.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.bmc.2023.117239
Trabalho de evento-resumo
Structural and biochemical characterization of SARS-CoV-2 main protease maturation process (2023)
Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Oliva, Glaucius ; Fernandes, Rafaela Sachetto
Fonte: Livro de Resumos. Nome do evento: Semana Integrada do Instituto de Física de São Carlos - SIFSC. Unidade: IFSC
Assuntos: COVID-19, BIOFÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Andre Schutzer de et al. Structural and biochemical characterization of SARS-CoV-2 main protease maturation process. 2023, Anais.. São Carlos: Instituto de Física de São Carlos - IFSC, 2023. Disponível em: https://repositorio.usp.br/directbitstream/64357321-8bd2-4d2c-9963-98f9c018e358/3180500.pdf. Acesso em: 08 out. 2025.
APA
Godoy, A. S. de, Noske, G. D., Oliva, G., & Fernandes, R. S. (2023). Structural and biochemical characterization of SARS-CoV-2 main protease maturation process. In Livro de Resumos. São Carlos: Instituto de Física de São Carlos - IFSC. Recuperado de https://repositorio.usp.br/directbitstream/64357321-8bd2-4d2c-9963-98f9c018e358/3180500.pdf
NLM
Godoy AS de, Noske GD, Oliva G, Fernandes RS. Structural and biochemical characterization of SARS-CoV-2 main protease maturation process [Internet]. Livro de Resumos. 2023 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/64357321-8bd2-4d2c-9963-98f9c018e358/3180500.pdf
Vancouver
Godoy AS de, Noske GD, Oliva G, Fernandes RS. Structural and biochemical characterization of SARS-CoV-2 main protease maturation process [Internet]. Livro de Resumos. 2023 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/64357321-8bd2-4d2c-9963-98f9c018e358/3180500.pdf
Artigo de periodico
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (2022)
Jansen, Jitske; Fernandes, Rafaela Sachetto ; Oliveira, Victor Gawriljuk Ferraro; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius
Fonte: Cell Stem Cell. Unidade: IFSC
Assuntos: CORONAVIRUS, COVID-19, RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANSEN, Jitske et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, v. 29, n. 2, p. 217-231 + e1-e8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.stem.2021.12.010. Acesso em: 08 out. 2025.
APA
Jansen, J., Fernandes, R. S., Oliveira, V. G. F., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., & Oliva, G. (2022). SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, 29( 2), 217-231 + e1-e8. doi:10.1016/j.stem.2021.12.010
NLM
Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010
Vancouver
Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010
Trabalho de evento-resumo periodico
A crystallographic snapshot of SARS-CoV-2 main protease maturation process (2022)
Oliva, Glaucius ; Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto; Lima, G. M. A.; Rosa, Higor Vinicius Dias; Pereira, Humberto d'Muniz ; Zeri, A. C. M.; Nascimento, A. F. Z.; Freire, Marjorie Caroline Liberato Cavalcanti; Godoy, Andre Schutzer de
Fonte: FEBS Open Bio. Nome do evento: Biochemistry Global Summit. Unidade: IFSC
Assuntos: CORONAVIRUS, ANTIVIRAIS, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVA, Glaucius et al. A crystallographic snapshot of SARS-CoV-2 main protease maturation process. FEBS Open Bio. Oxford: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/2211-5463.13440. Acesso em: 08 out. 2025. , 2022
APA
Oliva, G., Noske, G. D., Nakamura, A. M., Oliveira, V. G. F., Fernandes, R. S., Lima, G. M. A., et al. (2022). A crystallographic snapshot of SARS-CoV-2 main protease maturation process. FEBS Open Bio. Oxford: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.1002/2211-5463.13440
NLM
Oliva G, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Godoy AS de. A crystallographic snapshot of SARS-CoV-2 main protease maturation process [Internet]. FEBS Open Bio. 2022 ; 12 326-327.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/2211-5463.13440
Vancouver
Oliva G, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Lima GMA, Rosa HVD, Pereira H d'M, Zeri ACM, Nascimento AFZ, Freire MCLC, Godoy AS de. A crystallographic snapshot of SARS-CoV-2 main protease maturation process [Internet]. FEBS Open Bio. 2022 ; 12 326-327.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/2211-5463.13440
Artigo de periodico
Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate (2022)
Freire, Marjorie Caroline Liberato Cavalcanti ; Basso, Luís Guilherme Mansor; Mendes, Luís Felipe Santos ; Mesquita, Nathalya Cristina de Moraes Roso; Mottin, Melina; Fernandes, Rafaela Sachetto ; Policastro, Lucca Rocha ; Godoy, Andre Schutzer de ; Santos, Igor A. ; Ruiz, Uriel Enrique Aquino; Caruso, Icaro P.; Sousa, Bruna K. P.; Jardim, Ana C. G. ; Almeida, Fabio C. L.; Gil, Laura Helena Vega Gonzales; Andrade, Carolina H.; Oliva, Glaucius
Fonte: Scientific Reports. Unidades: IFSC, FFCLRP
Assuntos: VÍRUS CHIKUNGUNYA, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), QUÍMICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, v. 12, p. 10601-1-10601-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-14790-x. Acesso em: 08 out. 2025.
APA
Freire, M. C. L. C., Basso, L. G. M., Mendes, L. F. S., Mesquita, N. C. de M. R., Mottin, M., Fernandes, R. S., et al. (2022). Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, 12, 10601-1-10601-15. doi:10.1038/s41598-022-14790-x
NLM
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Vancouver
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Artigo de periodico
The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication (2022)
Policastro, Lucca Rocha ; Dolci, Isabela; Godoy, Andre Schutzer de ; Silva Júnior, José V. J.; Ruiz, Uriel Enrique Aquino; Santos, Igor A. ; Jardim, Ana C. G. ; Samby, Kirandeep; Burrows, Jeremy N.; Wells, Timothy N. C.; Gil, Laura Helena Vega Gonzales; Oliva, Glaucius ; Fernandes, Rafaela Sachetto
Fonte: Viruses. Unidade: IFSC
Assuntos: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLICASTRO, Lucca Rocha et al. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, v. 14, n. 7, p. 1351-1-1351-12, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14071351. Acesso em: 08 out. 2025.
APA
Policastro, L. R., Dolci, I., Godoy, A. S. de, Silva Júnior, J. V. J., Ruiz, U. E. A., Santos, I. A., et al. (2022). The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, 14( 7), 1351-1-1351-12. doi:10.3390/v14071351
NLM
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v14071351
Vancouver
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/v14071351
Artigo de periodico
Pyronaridine protects against SARS-CoV-2 infection in mouse (2022)
Puhl, Ana C. ; Gomes, Giovanni Freitas; Damasceno, Samara; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto ; Monakhova, Natalia; Riabova, Olga; Lane, Thomas R.; Makarov, Vadim; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Oliva, Glaucius ; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Fonte: ACS Infectious Diseases. Unidades: FMRP, IFSC
Assuntos: COVID-19, IMUNOLOGIA, AGENTES ANTIMICROBIANOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, v. 8, n. 6, p. 1147-1160, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.2c00091. Acesso em: 08 out. 2025.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., et al. (2022). Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, 8( 6), 1147-1160. doi:10.1021/acsinfecdis.2c00091
NLM
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Vancouver
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Artigo de periodico
Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model (2022)
Sadraeian, Mohammad ; Pinto-Júnior, Fabio Francisco ; Miranda, Marcela ; Galinskas, Juliana; Fernandes, Rafaela Sachetto ; Cruz, Edgar Ferreira da; Fu, Libing; Zhang, Le ; Diaz, Ricardo Sobhie; Miranda, Gustavo Cabral de ; Guimarães, Francisco Eduardo Gontijo
Fonte: Pharmaceutics. Unidades: IFSC, ICB
Assuntos: COVID-19, CORONAVIRUS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SADRAEIAN, Mohammad et al. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model. Pharmaceutics, v. 14, n. 3, p. 683-1-683-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14030683. Acesso em: 08 out. 2025.
APA
Sadraeian, M., Pinto-Júnior, F. F., Miranda, M., Galinskas, J., Fernandes, R. S., Cruz, E. F. da, et al. (2022). Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model. Pharmaceutics, 14( 3), 683-1-683-15. doi:10.3390/pharmaceutics14030683
NLM
Sadraeian M, Pinto-Júnior FF, Miranda M, Galinskas J, Fernandes RS, Cruz EF da, Fu L, Zhang L, Diaz RS, Miranda GC de, Guimarães FEG. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model [Internet]. Pharmaceutics. 2022 ; 14( 3): 683-1-683-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics14030683
Vancouver
Sadraeian M, Pinto-Júnior FF, Miranda M, Galinskas J, Fernandes RS, Cruz EF da, Fu L, Zhang L, Diaz RS, Miranda GC de, Guimarães FEG. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model [Internet]. Pharmaceutics. 2022 ; 14( 3): 683-1-683-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/pharmaceutics14030683

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos